Koge, Junpei http://orcid.org/0000-0002-9632-2164
Tanaka, Kanta
Yoshimoto, Takeshi
Shiozawa, Masayuki
Yamagami, Hiroshi
Satow, Tetsu
Takahashi, Jun C.
Ihara, Masafumi
Koga, Masatoshi
Kira, Jun-ichi
Toyoda, Kazunori
Funding for this research was provided by:
Grant-in-Aid for Scientific Research (20K16716)
Article History
Received: 12 October 2020
Revised: 6 January 2021
Accepted: 4 February 2021
First Online: 16 February 2021
Compliance with ethical standards
:
: Dr. Koge reports no disclosures. Dr. Tanaka reports lecturer’s fees from Daiichi-Sankyo, Medico’s Hirata, and Stryker. Dr. Yoshimoto reports lecture’s fees from Takeda Pharmaceutical. Dr. Shiozawa reports no disclosures. Dr. Yamagami reports research grants from Bristol-Myers Squibb; lecturer’s fees from Stryker, Terumo, Medtronic, Medico’s Hirata, Johnson and Johnson, Bayer, Daiichi-Sankyo, Bristol-Myers Squibb, Boehringer Ingelheim, Takeda, and Otsuka Pharmaceutical; and membership of the advisory boards for Daiichi-Sankyo and Biomedical Solutions. Dr. Satow reports research funding from CANON Medical System, lecture’s fees from Medtronic and Stryker. Dr. Takahashi reports no disclosures. Dr. Ihara reports lecturer’s fees from Daiichi Sankyo, Eisai, and Bayer, and grant support from Panasonic, Bristol-Myers Squibb, and Otsuka Pharmaceutical. Dr. Koga reports honoraria from Bayer Yakuhin, Bristol-Myers-Squibb, Otsuka, Daiichi-Sankyo, Nippon Boehringer Ingelheim and Takeda, scientific advisory board from Ono, and research supports from Takeda, Daiichi-Sankyo, Nippon Boehringer Ingelheim, Astellas, Pfizer and Shionogi, outside the submitted work. Dr. Kira reports no disclosures. Dr. Toyoda reports lecturer’s fees from Daiichi Sankyo, Boehringer Ingelheim, Bayer, and Bristol-Myers Squibb.
: This study was approved by the ethics committee of the National Cerebral and Cardiovascular Center, Japan (M23-073-7).